Published in Neuropediatrics on February 01, 2007
Progressive myoclonic epilepsies: definitive and still undetermined causes. Neurology (2014) 1.52
A new large animal model of CLN5 neuronal ceroid lipofuscinosis in Borderdale sheep is caused by a nucleotide substitution at a consensus splice site (c.571+1G>A) leading to excision of exon 3. Neurobiol Dis (2007) 1.02
Interactions of the proteins of neuronal ceroid lipofuscinosis: clues to function. Cell Mol Life Sci (2010) 0.93
Therapeutic approaches to the challenge of neuronal ceroid lipofuscinoses. Curr Pharm Biotechnol (2011) 0.92
Mass spectrometry-based protein profiling to determine the cause of lysosomal storage diseases of unknown etiology. Mol Cell Proteomics (2009) 0.91
Molecular epidemiology of childhood neuronal ceroid-lipofuscinosis in Italy. Orphanet J Rare Dis (2013) 0.86
Adult-onset autosomal recessive ataxia associated with neuronal ceroid lipofuscinosis type 5 gene (CLN5) mutations. J Neurol (2014) 0.80
The role of N-glycosylation in folding, trafficking, and functionality of lysosomal protein CLN5. PLoS One (2013) 0.80
Mastering the dilemma of rare diseases. Neuropediatrics (2007) 0.75
Using the social amoeba Dictyostelium to study the functions of proteins linked to neuronal ceroid lipofuscinosis. J Biomed Sci (2016) 0.75
Loss of CLN5 causes altered neurogenesis in a childhood neurodegenerative disorder. Dis Model Mech (2017) 0.75
Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science (1996) 11.59
An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature (1989) 3.75
Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency. Am J Hum Genet (1998) 3.08
Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement. Brain (2005) 2.88
Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat Genet (1998) 2.72
EFNS guidelines on diagnosis and treatment of primary dystonias. Eur J Neurol (2011) 2.63
Neurodegeneration associated with genetic defects in phospholipase A(2). Neurology (2008) 2.57
Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study. Neurology (2009) 2.33
Reliability of the North Star Ambulatory Assessment in a multicentric setting. Neuromuscul Disord (2009) 2.13
Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy. Neurology (2006) 2.11
Autosomal dominant cortical tremor, myoclonus and epilepsy: many syndromes, one phenotype. Acta Neurol Scand (2005) 2.09
Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study. Neurology (2011) 2.06
Serum lactate dehydrogenase as early marker of posterior reversible encephalopathy syndrome: keep your eyes open. Anaesth Intensive Care (2012) 2.01
Mutations in the gene encoding immunoglobulin mu-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1. Nat Genet (2001) 2.00
Periventricular heterotopia: phenotypic heterogeneity and correlation with Filamin A mutations. Brain (2006) 2.00
GJA12 mutations are a rare cause of Pelizaeus-Merzbacher-like disease. Neurology (2007) 1.93
The impact of climate and traffic-related NO2 on the prevalence of asthma and allergic rhinitis in Italy. Clin Exp Allergy (2002) 1.87
Oligophrenin 1 mutations frequently cause X-linked mental retardation with cerebellar hypoplasia. Neurology (2005) 1.85
Malformations in offspring of 305 epileptic women: a prospective study. Acta Neurol Scand (1992) 1.76
RYR1 mutations are a common cause of congenital myopathies with central nuclei. Ann Neurol (2010) 1.75
Periventricular heterotopia, mental retardation, and epilepsy associated with 5q14.3-q15 deletion. Neurology (2008) 1.74
Cerebellar ataxia and coenzyme Q10 deficiency. Neurology (2003) 1.73
Congenital malformations due to antiepileptic drugs. Epilepsy Res (1999) 1.71
Effectiveness of anthracycline against experimental prion disease in Syrian hamsters. Science (1997) 1.70
Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI. Proc Natl Acad Sci U S A (2001) 1.69
Transporters in drug-refractory epilepsy: clinical significance. Clin Pharmacol Ther (2010) 1.67
GLUT1 mutations are a rare cause of familial idiopathic generalized epilepsy. Neurology (2012) 1.67
Predicting tuberculosis treatment outcome in a low-incidence area. Int J Tuberc Lung Dis (2008) 1.66
Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineurs. Neurology (2009) 1.65
Are asthma-like symptoms due to bronchial or extrathoracic airway dysfunction? Lancet (1995) 1.63
The effect of genotype on the natural history of eIF2B-related leukodystrophies. Neurology (2004) 1.63
Genome search for susceptibility loci of common idiopathic generalised epilepsies. Hum Mol Genet (2000) 1.61
Hyperresponsiveness of the extrathoracic airway in patients with captopril-induced cough. Chest (1990) 1.60
A new syndrome with ethylmalonic aciduria and normal fatty acid oxidation in fibroblasts. J Pediatr (1994) 1.59
Mitochondrial encephalomyopathy with coenzyme Q10 deficiency. Neurology (1997) 1.58
An open-label trial of levetiracetam in severe myoclonic epilepsy of infancy. Neurology (2007) 1.56
The role of muscle biopsy in investigating isolated muscle pain. Neurology (2007) 1.54
Genetic diagnosis in Lafora disease: genotype-phenotype correlations and diagnostic pitfalls. Neurology (2007) 1.53
Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. J Neuropathol Exp Neurol (1999) 1.49
NPHP1 gene deletion is a rare cause of Joubert syndrome related disorders. J Med Genet (2005) 1.47
Axonal swellings predict the degeneration of epidermal nerve fibers in painful neuropathies. Neurology (2003) 1.46
Spectrum of SCN1A mutations in severe myoclonic epilepsy of infancy. Neurology (2003) 1.45
Early-onset progressive ataxia associated with the first CACNA1A mutation identified within the I-II loop. J Neurol Sci (2007) 1.44
Trends in the prevalence of asthma and allergic rhinitis in Italy between 1991 and 2010. Eur Respir J (2011) 1.44
Cerebroretinal microangiopathy with calcifications and cysts (CRMCC). Am J Med Genet A (2008) 1.44
Epilepsia partialis continua and neuronal migration anomalies. Brain Dev (1992) 1.44
Mitochondrial myopathy, parkinsonism, and multiple mtDNA deletions in a Sephardic Jewish family. Neurology (2001) 1.43
An undetected burden of asthma in Italy: the relationship between clinical and epidemiological diagnosis of asthma. Eur Respir J (1998) 1.43
Lipoid proteinosis: case report and review of the literature. Acta Otorhinolaryngol Ital (2006) 1.42
Grazing in a turbulent environment: energy dissipation, encounter rates, and efficacy of feeding currents in Centropages hamatus. Proc Natl Acad Sci U S A (1990) 1.42
Pallidal stimulation for acquired dystonia due to cerebral palsy: beyond 5 years. Eur J Neurol (2014) 1.39
Infantile neuroaxonal dystrophy: neuroradiological studies in 11 patients. Neuroradiology (1999) 1.37
Nonresponse bias in EC Respiratory Health Survey in Italy. Eur Respir J (1994) 1.37
L-2-hydroxyglutaric aciduria and brain malignant tumors: a predisposing condition? Neurology (2004) 1.36
Homozygosity mapping of Hallervorden-Spatz syndrome to chromosome 20p12.3-p13. Nat Genet (1996) 1.36
Diagnostic imaging in 13 cases of Rasmussen's encephalitis: can early MRI suggest the diagnosis? Neuroradiology (2003) 1.31
Infantile Alexander disease: spectrum of GFAP mutations and genotype-phenotype correlation. Am J Hum Genet (2001) 1.30
Clinical and molecular features of mitochondrial DNA depletion due to mutations in deoxyguanosine kinase. Hum Mutat (2008) 1.27
Clinical and molecular characterisation of 80 patients with 5p deletion: genotype-phenotype correlation. J Med Genet (2001) 1.26
Quality-of-life and asthma-severity in general population asthmatics: results of the ECRHS II study. Allergy (2008) 1.26
Novel SACS mutations in autosomal recessive spastic ataxia of Charlevoix-Saguenay type. Neurology (2004) 1.26
Autosomal recessive rolandic epilepsy with paroxysmal exercise-induced dystonia and writer's cramp: delineation of the syndrome and gene mapping to chromosome 16p12-11.2. Ann Neurol (1999) 1.23
Glutathione in blood of patients with Friedreich's ataxia. Eur J Clin Invest (2001) 1.22
Undetected burden of tuberculosis in a low-prevalence area. Int J Tuberc Lung Dis (2006) 1.22
Collagen VI deficiency affects the organization of fibronectin in the extracellular matrix of cultured fibroblasts. Matrix Biol (2001) 1.22
Idiopathic partial epilepsy with auditory features (IPEAF): a clinical and genetic study of 53 sporadic cases. Brain (2004) 1.22
Band heterotopia: correlation of outcome with magnetic resonance imaging parameters. Ann Neurol (1994) 1.22
Phosphomannose isomerase deficiency: a carbohydrate-deficient glycoprotein syndrome with hepatic-intestinal presentation. Am J Hum Genet (1998) 1.20
Clinical and genetic heterogeneity of branching enzyme deficiency (glycogenosis type IV). Neurology (2004) 1.19
Genotype-phenotype correlation of paroxysmal nonkinesigenic dyskinesia. Neurology (2007) 1.19
Familial basilar migraine associated with a new mutation in the ATP1A2 gene. Neurology (2005) 1.19
Hemimegalencephaly and intractable epilepsy: benefits of hemispherectomy. Epilepsia (1990) 1.16
McArdle disease: a clinical review. J Neurol Neurosurg Psychiatry (2010) 1.16
A novel mutation in SACS gene in a family from southern Italy. Neurology (2004) 1.15
Mutations in the MTM1 gene implicated in X-linked myotubular myopathy. ENMC International Consortium on Myotubular Myopathy. European Neuro-Muscular Center. Hum Mol Genet (1997) 1.15
Ataxia with oculomotor apraxia type 2: a clinical, pathologic, and genetic study. Neurology (2006) 1.15
Management of multidrug-resistant tuberculosis in Italy. Int J Tuberc Lung Dis (2005) 1.13
A new mtDNA mutation in the tRNA(Leu(UUR)) gene associated with maternally inherited cardiomyopathy. Hum Mutat (1994) 1.13
West syndrome associated with 14q12 duplications harboring FOXG1. Neurology (2011) 1.12
Giant dystrophin deletion associated with congenital cataract and mild muscular dystrophy. Neurology (1998) 1.12
Malformations in offspring of women with epilepsy: a prospective study. Epilepsia (1999) 1.12
Paroxysmal movement disorders in GLUT1 deficiency syndrome. Neurology (2008) 1.10
Dominantly inherited mitochondrial myopathy with multiple deletions of mitochondrial DNA: clinical, morphologic, and biochemical studies. Neurology (1991) 1.10